Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge

Sponsor
University Medical Center Groningen (Other)
Overall Status
Completed
CT.gov ID
NCT02731976
Collaborator
(none)
21
1
1
30
0.7

Study Details

Study Description

Brief Summary

Changes in the gut microbiomes of healthy volunteers who followed a gluten-free diet (GFD) for four weeks were studied. Per participant, nine stool samples were collected: one at baseline, four during the GFD period, and four when they returned to their habitual diet. Microbiome profiles were determined using 16S rRNA sequencing and the samples were next processed for taxonomic and imputed functional composition. Additionally, participants kept a 3-day food diary and six gut health-related biomarkers were measured.

Condition or Disease Intervention/Treatment Phase
  • Other: Dietary intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
21 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Influence of a Short-term Gluten-free Diet on the Human Gut Microbiome
Study Start Date :
Nov 1, 2011
Actual Primary Completion Date :
Feb 1, 2012
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: GFD

After instruction of a dietician, participants adhered to a gluten-free diet for 4 weeks.

Other: Dietary intervention

Outcome Measures

Primary Outcome Measures

  1. Changes in gut microbiota composition upon gluten-free diet intervention [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

Secondary Outcome Measures

  1. Changes in gut associated biomarker levels: fecal calprotectin [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  2. Changes in gut associated biomarker levels: plasma cytokines: IL-1beta [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  3. Changes in gut associated biomarker levels: fecal human beta defensin 2 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  4. Changes in gut associated biomarker levels: fecal chromogranin A [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  5. Changes in gut associated biomarker levels: fecal short chain fatty acids: propionate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  6. Changes in gut associated biomarker levels: plasma citrulline [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  7. Changes in gut associated biomarker levels: fecal short chain fatty acids: acetate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  8. Changes in gut associated biomarker levels: fecal short chain fatty acids: butyrate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  9. Changes in gut associated biomarker levels: fecal short chain fatty acids: valerate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  10. Changes in gut associated biomarker levels: fecal short chain fatty acids: caproate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  11. Changes in gut associated biomarker levels: plasma cytokines: IL-6 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  12. Changes in gut associated biomarker levels: plasma cytokines: IL-8 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  13. Changes in gut associated biomarker levels: plasma cytokines: IL-10 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  14. Changes in gut associated biomarker levels: plasma cytokines: IL-12 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

  15. Changes in gut associated biomarker levels: plasma cytokines: TNFalpha [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy participants aged >=16
Exclusion Criteria:
  • Known gastrointestinal disorder

  • Known food intolerance

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Groningen Groningen Netherlands 9700 RB

Sponsors and Collaborators

  • University Medical Center Groningen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alexandra Zhernakova, Dr, University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT02731976
Other Study ID Numbers:
  • M12.113965
First Posted:
Apr 8, 2016
Last Update Posted:
Apr 11, 2016
Last Verified:
Apr 1, 2016
Keywords provided by Alexandra Zhernakova, Dr, University Medical Center Groningen

Study Results

No Results Posted as of Apr 11, 2016